Animal models of prostate cancer have demonstrated that, at least in rats, estrogen is a necessary, if not sufficient, condition for prostate carcinogenesis.

HR biomarker testing is primarily done via immunohistochemistry (IHC) and detects the presence of estrogen receptors (ERs) and progesterone receptors (PRs) on cancer cells. Breast cancers that test ...

Many HER2-targeting therapies require pre-treatment HER2 testing. HER2 biomarker tests are used to determine whether the ...

Next-generation selective estrogen receptor degraders and other novel endocrine therapies for management of metastatic hormone receptor-positive breast cancer: current and emerging role.

Researchers reviewed national database records on 18,620 female breast cancer patients aged 65 and older who were diagnosed between 2010-2017, including 800 who used vaginal estrogen creams.

Dr. Gray emphasized that women unsure about their hormone levels should consider asking their doctor for a blood test to ...

Hormone therapy for breast cancer slows or stops the growth of hormone-sensitive tumors and is not the same as hormone replacement therapy.

Breast cancer types, staging, diagnosis, treatment, and survivorship are complex, but understanding them helps patients make ...

Hormone replacement therapy helps women counteract the side effects of menopause. But could it also increase the odds of getting cancer? Cindy Matsen, MD, talks through the risks and benefits.

Flaxseeds and Cancer Warnings: What Are the Claims? Flaxseeds and hormonal cancer have a complex relationship. Flaxseeds are rich sources of plant-based compounds called lignans. These compounds ...

Estrogen is now implicated as a potential agent in the development and progression of prostate cancer.